1. Home
  2. SRBK vs PMVP Comparison

SRBK vs PMVP Comparison

Compare SRBK & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRBK
  • PMVP
  • Stock Information
  • Founded
  • SRBK 1887
  • PMVP 2013
  • Country
  • SRBK United States
  • PMVP United States
  • Employees
  • SRBK N/A
  • PMVP N/A
  • Industry
  • SRBK
  • PMVP Medicinal Chemicals and Botanical Products
  • Sector
  • SRBK
  • PMVP Health Care
  • Exchange
  • SRBK Nasdaq
  • PMVP Nasdaq
  • Market Cap
  • SRBK 95.0M
  • PMVP 85.5M
  • IPO Year
  • SRBK N/A
  • PMVP 2020
  • Fundamental
  • Price
  • SRBK $11.04
  • PMVP $1.61
  • Analyst Decision
  • SRBK
  • PMVP Strong Buy
  • Analyst Count
  • SRBK 0
  • PMVP 4
  • Target Price
  • SRBK N/A
  • PMVP $5.75
  • AVG Volume (30 Days)
  • SRBK 29.9K
  • PMVP 172.8K
  • Earning Date
  • SRBK 01-01-0001
  • PMVP 11-07-2024
  • Dividend Yield
  • SRBK N/A
  • PMVP N/A
  • EPS Growth
  • SRBK N/A
  • PMVP N/A
  • EPS
  • SRBK 0.11
  • PMVP N/A
  • Revenue
  • SRBK $30,867,000.00
  • PMVP N/A
  • Revenue This Year
  • SRBK N/A
  • PMVP N/A
  • Revenue Next Year
  • SRBK N/A
  • PMVP N/A
  • P/E Ratio
  • SRBK $96.18
  • PMVP N/A
  • Revenue Growth
  • SRBK 164.18
  • PMVP N/A
  • 52 Week Low
  • SRBK $8.94
  • PMVP $1.40
  • 52 Week High
  • SRBK $11.28
  • PMVP $3.47
  • Technical
  • Relative Strength Index (RSI)
  • SRBK 51.56
  • PMVP 49.19
  • Support Level
  • SRBK $10.75
  • PMVP $1.54
  • Resistance Level
  • SRBK $11.11
  • PMVP $1.65
  • Average True Range (ATR)
  • SRBK 0.15
  • PMVP 0.08
  • MACD
  • SRBK -0.01
  • PMVP -0.01
  • Stochastic Oscillator
  • SRBK 54.72
  • PMVP 25.00

About SRBK SR Bancorp Inc. Common stock

SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.

About PMVP PMV Pharmaceuticals Inc.

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

Share on Social Networks: